Androgenetic alopecia AGA
Conditions
Interventions
Apply to the area of the scalp where the test site is shaved with an electric shaver, under the following conditions.
Apply 0.5mL of the SCALP-D Medical Minoxi 5 to the irradiated and non-irradiated a
Sponsors
Ogawa Rei
Takada Hiroya
ANGFA Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Over 20 years old males who are understood the research and agreed to it. 2) 20 AGA patients (Hamilton-Norwood classification type III-vertex to V)
Exclusion criteria
Exclusion criteria: 1) Patients undergoing treatment for AGA who have had a satisfactory response to previous treatment 2) Patients who are judged by the participating physicians to be inappropriate to conduct this study 3) Patients who have participated in another clinical trial or clinical study in the past six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phototricogram assessment of the study site at 12 and 24 weeks (% of growing hairs) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Phototrichogram evaluation of the test site (hair density, hair diameter, hair elongation, and binarization) 2. The doctor's findings on the skin of the irradiated area (bleeding, erythema, purpura, papule, nodule, erosion, ulcer) 3. Experiential questionnaire evaluation by the research subjects | — |
Contacts
Public ContactTakanori Hama
ANGFA Co., Ltd.
Outcome results
None listed